ITOC.US iTonic Holdings Ltd.
- Market cap
- USD 14.5M
- P/E
- -
- P/B
- 0.61x
- ROE
- -99.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is ITOC.US undervalued?
Graham numberThe Graham number of iTonic Holdings Ltd. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
iTonic Holdings Ltd. fundamental analysis
No fundamental analysis for iTonic Holdings Ltd. yet.
iTonic Holdings Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About iTonic Holdings Ltd.
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could dete…
Full company profileiTonic Holdings Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
iTonic Holdings Ltd. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 703K | 680K | 629K | 448K | 523K | 404K |
| Gross Profit | 591K | 558K | 471K | 345K | 327K | -356K |
| Operating Income | 138K | 27.5K | -307K | -770K | -5.19M | -20.3M |
| EBITDA | 269K | 125K | -197K | -566K | -5.17M | -19.7M |
| Net Income | 192K | 84.0K | -241K | -661K | -5.10M | -23.4M |
| EPS | 0.21 | 0.09 | -0.27 | -0.83 | -5.09 | -5.22 |
| Balance Sheet | ||||||
| Total Assets | 1.33M | 1.40M | 1.62M | 6.72M | 9.10M | 26.6M |
| Total Liabilities | 377K | 845K | 1.32M | 539K | 970K | 1.92M |
| Shareholders' Equity | 954K | 556K | 306K | 6.18M | 6.12M | 23.6M |
| Cash & Short-term Investments | 137K | 72.3K | 227K | 6.16M | 2.93M | 2.22M |
| Total Debt | 297K | 218K | 156K | 248K | 143K | 244K |
| Cash Flow | ||||||
| Operating Cash Flow | 80.8K | -116K | -63.6K | -775K | -3.24M | -2.94M |
| Capital Expenditure | 5.00 | 2.00 | 4.00 | 859.00 | 3.81K | 9.62K |
| Free Cash Flow | 80.8K | -116K | -63.6K | -776K | -3.24M | -2.95M |
| Ratios | ||||||
| ROE | 20.2% | 15.1% | -78.8% | -10.7% | -83.3% | -99.4% |
| ROA | 14.5% | 6.0% | -14.8% | -9.8% | -56.0% | -88.1% |
| Net Profit Margin | 27.4% | 12.4% | -38.4% | -147.4% | -974.7% | -5,802.8% |
| Debt to Equity | 0.31x | 0.39x | 0.51x | 0.04x | 0.02x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
iTonic Holdings Ltd. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 398K | 0.44 | 474.5% |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:16 on Oct 6, 2026.
Who owns iTonic Holdings Ltd.
- Insiders 1.82%
- Institutions 0.20%
- Public & others 97.98%
- Shares outstanding 6.84M
- Free float 6.71M
Top funds holding ITOC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BSF Systematic US Eq Abs Ret A2 USD | 780.00 | 0.00% | 0.00% | Dec 2025 |
Top institutions holding ITOC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| XTX Topco Ltd | 75.9K | 0.06% | +57.04% | Jun 2026 |
| Citadel Advisors Llc | 43.4K | 0.04% | +46.78% | Jun 2026 |
| Virtu Financial LLC | 38.6K | 0.03% | 0.00% | Jun 2026 |
| UBS Group AG | 33.3K | 0.03% | 0.00% | Jun 2026 |
| Jane Street Group LLC | 17.8K | 0.02% | 0.00% | Jun 2026 |
| StoneX Group Inc | 11.0K | 0.01% | 0.00% | Jun 2026 |
| Point72 Asset Management, L.P. | 10.9K | 0.01% | 0.00% | Jun 2026 |
| NATIONAL BANK OF CANADA /FI/ | 1.80K | 0.00% | 0.00% | Jun 2026 |
| BlackRock Inc | 618.00 | 0.00% | 0.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 473.00 | 0.00% | 0.00% | Jun 2026 |
| Compagnie Lombard, Odier SCA | 140.00 | 0.00% | 0.00% | Jun 2026 |
| Cygnus Capital Advisors, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Renaissance Technologies Corp | 0.00 | 0.00% | -100.00% | Sep 2026 |
iTonic Holdings Ltd. company profile
- Company name
- iTonic Holdings Ltd.
- Ticker
- ITOC.US
- ISIN
- KYG713991027
- Exchange
- USA Stocks
- Listed since
- Sep 5, 2024
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 7
- Fiscal year end
- December
- Address
- NET Building, Beijing, China, 100101
- Phone
- 86 10 8496 6987
- Website
- ftzy.com.cn
About iTonic Holdings Ltd.
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.
iTonic Holdings Ltd. management
2- Mr. Jianfei ZhangCEO & Chairman of the Board · born 1972
- Ms. Simin TanChief Financial Officer · born 1995